rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Lisa Ann Rometty

Director

Company insider

Files Form 4 as: Director, Rani Therapeutics Holdings.

In numbers

Trades disclosed
15
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
3 Jan 2022
Last trade
28 May 2026
Last filed
1 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
RANI Rani Therapeutics HoldingsDirector · Biotechnology · last 28 May 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
28 May 2026filed 1 Jun 2026RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—123,600 at $0.00filing
28 May 2026filed 1 Jun 2026RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—123,600 at $0.00filing
28 May 2025filed 30 May 2025RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
16 Dec 2024filed 17 Dec 2024RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code D—101,276filing
16 Dec 2024filed 17 Dec 2024RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—101,276filing
16 Dec 2024filed 17 Dec 2024RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code D—17,708filing
16 Dec 2024filed 17 Dec 2024RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—17,708filing
29 May 2024filed 30 May 2024RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
16 Dec 2023filed 19 Dec 2023RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code D—101,276filing
16 Dec 2023filed 19 Dec 2023RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—101,276filing
16 Dec 2023filed 19 Dec 2023RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code D—17,708filing
16 Dec 2023filed 19 Dec 2023RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—17,708filing
25 May 2023filed 30 May 2023RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—101,276 at $0.00filing
25 May 2022filed 27 May 2022RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—16,112 at $0.00filing
3 Jan 2022filed 5 Jan 2022RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—49,037 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Talat ImranChief Executive Officer · Chief Executive Officer at Rani Therapeutics Holdings, filing Form 4 there in the last year
Alireza JavadiChief Technical Officer · Chief Technical Officer at Rani Therapeutics Holdings, filing Form 4 there in the last year
Michelle GilsonDirector · Director at Rani Therapeutics Holdings, filing Form 4 there in the last year
Mir A. ImranDirector and 10% owner · Director and 10% owner at Rani Therapeutics Holdings, filing Form 4 there in the last year
Nicholas MaestasChief Financial Officer · Chief Financial Officer at Rani Therapeutics Holdings, filing Form 4 there in the last year